MMN-407
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MMN-407, covering 2023-08-18 to 2023-08-18. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults [Phase 3]